Skip to main content

Tower Research Capital LLC (TRC)

Position in NVS — Novartis AG

CIK 1533421 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$313
-$4,016,943 QoQ
Shares Held
2
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,601
of 1,603 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $110,167,581 across 17 Drug Manufacturers - General names. NVS ranks #17 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $313 2
2025-12-31 $4,017,256 29,138
2025-09-30 $164,788 1,285
2025-06-30 $193,010 1,595
2025-03-31 $9,475 85
2024-12-31 $1,089,579 11,197
2024-09-30 $11,732 102
2024-06-30 $44,287 416
2024-03-31 $364,961 3,773
2023-12-31 $665,089 6,587
2023-09-30 $125,389 1,231
2023-06-30 $7,770 77
2023-03-31 $9,200 100
2022-12-31 $135,534 1,494
2022-09-30 $87,486 1,151
2022-06-30 $863,135 10,211
2022-03-31 $229,641 2,617
2021-12-31 $893,505 10,215
2021-09-30 $16,356 200
2021-06-30 $588,133 6,446
2021-03-31 $684,693 8,010
2020-12-31 $18,886 200
2020-09-30 $384,971 4,427
2020-03-31 $361,790 4,388